REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/04/2026
Back to search
Official data from USPTO
BIT-MAP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
05/05/2026
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
02/06/2020
Registration date
05/04/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/04/2021
Last transaction
05/05/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
JP
Examiner
FOSDICK, GEOFFREY A
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
bitBiome, Inc.
Representatives
Stacey J. Watson, Esq. Markery Law LLC
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of allergiesalzheimer diseaseadrenocortical insufficiencyallotype pneumoniaalveobronchiolitisangiocholitisarthritisasthmatoid bronchitisasthmaattention deficit hyperactivity disorderautismauto-immune diseases and disordersautoinflammatory diseasebacteremiabacterial infectionbacterial pneumoniabacterial septicemiabacteroides fragilisbacteroides thetaiotaomicronbacteroides uniformisbacteroides vulgatusbeta thalassemia and myelodysplastic syndromesbiliary tract cancerpneumoniablood diseaseblood disordersbone growth disordersbone and joint infectionsbreast cancerbronchitisbronchiectasiscancercardiovascular diseasescentral nervous system diseases and disorderscervical cancercholecystitischronic congestive heart failureclostridium perfringenscollagen diseasescolorectal cancercommunity-acquired pneumoniacongestive heart failureconstipationcrohn's diseasecystitisdeep suppurative diseasedementiadepressiondiabetesdermatologic diseasesduodenal ulcerdysenteryedematous statesendocarditisendocrine diseases and disordersendometrial cancerendometriosisendonephritisenteritisenterococcus faecalisepididymitisepilepsyesophageal cancerdysenteryfebrile neutropenic infectionsgastrointestinal diseases and disordersgastric cancergastric ulcergenetic diseases and disordersgonorrheagraft-versus-host diseasegranulocytopeniagynecological infectionshead and neck cancerheart diseasehematologic disordershepatic cirrhosishypertensionhyperlipidemihypercholesterolemiahypognathadenitisincontinenceinflammation and inflammatory diseasesinflammatory bowel diseaseintra-abdominal infectionsintrauterine infectionirritable bowel syndromekidney diseases and disordersleukemialiver disorders and diseaseslower respiratory tract infectionslung cancerlymphomamelanomameningitismenopausalmetabolic diseases and disordersmultiple myelomamultiple sclerosismuscular dystrophymusculoskeletal diseases and disordersmyeloproliferative diseasesmyelofibrosisnasosinusitisneoplastic diseasesneurodegenerative diseases and disordersneurological diseases and disordersneuromuscular and non-gonococcal urethritisnosocomial pneumoniaobesityobsessive-compulsive disorderoncological diseases and disordersophthalmic diseasesosteoarthritisotitis mediaovarian cancerpainpancreatic cancerparkinson's diseasepeptostreptococcus microsperitonitis and septicemiapneumoniapolymicrobic infectionsprevention of chest painprostate cancerprostatitispseudomonas aeruginosapyelocystitipyelonephritisreflux sophagitisrenal dysfunctionrheumatic disordersrespiratory diseasesrespiratory tract infectionsschizophreniasclerodermaseizuressepticemiasexual disfunctionsickle cell diseaseskin disorders and diseasesskin and skin structure infectionssolid organ transplant rejectionspasmsstaphylococcus aureusstreptococcus anginosusstreptococcus intermadiusstreptococcus constellatusstrokesuperficial pyogenic infectionsuppurative lung diseasesyphilistransmissible alimentary toxicosisthe prevention of organ rejection by renal transplant patientstumorsulcerative colitisurethritisurinary tract infectionsurogenital tract infectionurothelial cancervaso-occulisive crisisviral diseases and disorderszollinger-ellison syndrome; pharmaceutical biological preparations for medical purposes for the treatment of allergiesalzheimer diseaseadrenocortical insufficiencyallotype pneumoniaalveobronchiolitisangiocholitisarthritisasthmatoid bronchitisasthmaattention deficit hyperactivity disorderautismauto-immune diseases and disordersautoinflammatory diseasebacteremiabacterial infectionbacterial pneumoniabacterial septicemiabacteroides fragilisbacteroides thetaiotaomicronbacteroides uniformisbacteroides vulgatusbeta thalassemia and myelodysplastic syndromesbiliary tract cancerpneumoniablood diseaseblood disordersbone growth disordersbone and joint infectionsbreast cancerbronchitisbronchiectasiscancercardiovascular diseasescentral nervous system diseases and disorderscervical cancercholecystitischronic congestive heart failureclostridium perfringenscollagen diseasescolorectal cancercommunity-acquired pneumoniacongestive heart failureconstipationcrohn's diseasecystitisdeep suppurative diseasedementiadepressiondiabetesdermatologic diseasesduodenal ulcerdysenteryedematous statesendocarditisendocrine diseases and disordersendometrial cancerendometriosisendonephritisenteritisenterococcus faecalisepididymitisepilepsyesophageal cancerdysenteryfebrile neutropenic infectionsgastrointestinal diseases and disordersgastric cancergastric ulcergenetic diseases and disordersgonorrheagraft-versus-host diseasegranulocytopeniagynecological infectionshead and neck cancerheart diseasehematologic disordershepatic cirrhosishypertensionhyperlipidemihypercholesterolemiahypognathadenitisincontinenceinflammation and inflammatory diseasesinflammatory bowel diseaseintra-abdominal infectionsintrauterine infectionirritable bowel syndromekidney diseases and disordersleukemialiver disorders and diseaseslower respiratory tract infectionslung cancerlymphomamelanomameningitismenopausalmetabolic diseases and disordersmultiple myelomamultiple sclerosismuscular dystrophymusculoskeletal diseases and disordersmyeloproliferative diseasesmyelofibrosisnasosinusitisneoplastic diseasesneurodegenerative diseases and disordersneurological diseases and disordersneuromuscular and non-gonococcal urethritisnosocomial pneumoniaobesityobsessive-compulsive disorderoncological diseases and disordersophthalmic diseasesosteoarthritisotitis mediaovarian cancerpainpancreatic cancerparkinson's diseasepeptostreptococcus microsperitonitis and septicemiapneumoniapolymicrobic infectionsprevention of chest painprostate cancerprostatitispseudomonas aeruginosapyelocystitipyelonephritisreflux sophagitisrenal dysfunctionrheumatic disordersrespiratory diseasesrespiratory tract infectionsschizophreniasclerodermaseizuressepticemiasexual disfunctionsickle cell diseaseskin disorders and diseasesskin and skin structure infectionssolid organ transplant rejectionspasmsstaphylococcus aureusstreptococcus anginosusstreptococcus intermadiusstreptococcus constellatusstrokesuperficial pyogenic infectionsuppurative lung diseasesyphilistransmissible alimentary toxicosisthe prevention of organ rejection by renal transplant patientstumorsulcerative colitisurethritisurinary tract infectionsurogenital tract infectionurothelial cancervaso-occulisive crisisviral diseases and disorderszollinger-ellison syndrome; pharmaceutical preparations for human useanalgesicsantibioticsanti-fungalsanti-infective preparationsanti-viralsanti-parasiticscytokine inhibitory drugs; human growth hormonesimmunosuppressantsimmunotherapies for the treatment of cancermedicated dermatological preparationspharmaceutical antibodies for disease testingdiagnosistreatment purposespharmaceutical preparations that modulate the immune systempharmaceutical and biological preparations for immunotherapyincluding T Cell therapysedativessmoking cessation preparationstranquillizersvaccines for human usevitamins; preparations for destroying verminfungicidesherbicides
Class 42
Structural and functional analysis of genomes; research and development in the field of microorganisms and cells for the healthcarescientificbiochemicalpharmaceuticalmedicalagriculturalfoodcosmeticanimal healthdiagnosticchemicalbioremediationsanitationoral careoil industries; pharmaceutical research and development; pharmaceutical product evaluation services; medical research; medical laboratory research in the field of genetics; scientific laboratory services in the field of gene expression; scientific research relating to genetics
Class 44
Medical screening; providing information relating to medical services; medical testing and physical examination for diagnostic or treatment purposes
Publications
History of USPTO decisions and trademark events.
28 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/19/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/05/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/12/2021
FIMP
FINAL DISPOSITION PROCESSED
08/12/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/04/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
05/04/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/16/2021
PUBO
PUBLISHED FOR OPPOSITION
02/16/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/27/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/08/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
01/08/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/08/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
01/08/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/08/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/07/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/07/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/07/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/07/2020
RFRR
REFUSAL PROCESSED BY MPU
09/03/2020
MAFR
APPLICATION FILING RECEIPT MAILED
08/07/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/04/2020
CNRT
NON-FINAL ACTION WRITTEN
08/03/2020
DOCK
ASSIGNED TO EXAMINER
08/03/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/03/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/30/2020
Continuous trademark protection
Get notified about every new filing that threatens BIT-MAP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.